Biosysen Limited (HKG:1355)
Hong Kong
· Delayed Price · Currency is HKD 0.135
+0.008 (6.30%)
Apr 29, 2026, 3:36 PM HKT
Biosysen Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 51.31 | 40.68 | 67.66 | 63 | 70.56 | Upgrade
|
| Revenue Growth (YoY) | 26.11% | -39.87% | 7.40% | -10.72% | 39.24% | Upgrade
|
| Cost of Revenue | 36.87 | 19.02 | 22.31 | 26.09 | 25.07 | Upgrade
|
| Gross Profit | 14.43 | 21.67 | 45.35 | 36.91 | 45.5 | Upgrade
|
| Selling, General & Admin | 2.65 | - | - | - | - | Upgrade
|
| Other Operating Expenses | 28.75 | 9.72 | 10.88 | 12.72 | 10.61 | Upgrade
|
| Operating Expenses | 46.61 | 20.04 | 54.62 | 43.58 | 40.72 | Upgrade
|
| Operating Income | -32.18 | 1.63 | -9.26 | -6.67 | 4.77 | Upgrade
|
| Interest Expense | -4.88 | -5.86 | -5.77 | -7.37 | -8.08 | Upgrade
|
| Interest & Investment Income | 0 | 0.01 | 0 | 0.01 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -37.08 | -4.24 | -15.05 | -14.05 | -3.3 | Upgrade
|
| Impairment of Goodwill | - | - | -1.86 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -2.01 | -1.86 | 1.42 | 2.75 | Upgrade
|
| Asset Writedown | -10.22 | -30.82 | -39.9 | - | - | Upgrade
|
| Other Unusual Items | 1.92 | - | - | -3.48 | 0.4 | Upgrade
|
| Pretax Income | -45.38 | -37.08 | -58.67 | -16.1 | -0.15 | Upgrade
|
| Income Tax Expense | - | 2.69 | 3.1 | 1.54 | 3.87 | Upgrade
|
| Earnings From Continuing Operations | -45.38 | -39.76 | -61.77 | -17.65 | -4.02 | Upgrade
|
| Minority Interest in Earnings | 1.85 | 18.64 | 23.59 | 9.85 | 8.99 | Upgrade
|
| Net Income | -43.53 | -21.12 | -38.18 | -7.79 | 4.98 | Upgrade
|
| Net Income to Common | -43.53 | -21.12 | -38.18 | -7.79 | 4.98 | Upgrade
|
| Net Income Growth | - | - | - | - | 141.25% | Upgrade
|
| Shares Outstanding (Basic) | 965 | 473 | 448 | 448 | 448 | Upgrade
|
| Shares Outstanding (Diluted) | 965 | 473 | 448 | 448 | 448 | Upgrade
|
| Shares Change (YoY) | 103.95% | 5.52% | - | - | - | Upgrade
|
| EPS (Basic) | -0.05 | -0.04 | -0.09 | -0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.04 | -0.09 | -0.02 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | 141.34% | Upgrade
|
| Free Cash Flow | - | 24.01 | 34.51 | 6.41 | 14.06 | Upgrade
|
| Free Cash Flow Per Share | - | 0.05 | 0.08 | 0.01 | 0.03 | Upgrade
|
| Gross Margin | 28.13% | 53.26% | 67.03% | 58.58% | 64.48% | Upgrade
|
| Operating Margin | -62.72% | 4.01% | -13.69% | -10.58% | 6.77% | Upgrade
|
| Profit Margin | -84.85% | -51.91% | -56.43% | -12.37% | 7.05% | Upgrade
|
| Free Cash Flow Margin | - | 59.02% | 51.01% | 10.17% | 19.92% | Upgrade
|
| EBITDA | -24.63 | 9.18 | -0.42 | 2.69 | 12.93 | Upgrade
|
| EBITDA Margin | -48.01% | 22.56% | -0.61% | 4.28% | 18.33% | Upgrade
|
| D&A For EBITDA | 7.55 | 7.55 | 8.85 | 9.36 | 8.16 | Upgrade
|
| EBIT | -32.18 | 1.63 | -9.26 | -6.67 | 4.77 | Upgrade
|
| EBIT Margin | -62.72% | 4.01% | -13.69% | -10.58% | 6.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.